Alternative protein: it’s what’s for dinner

Catalyst · 14 Apr 2022 · 50m

What this episode covers

Dr. Liz Specht, VP of Science and Technology at the Good Food Institute, explains the three pillars of alternative protein: plant-based, microbial fermentation, and cultivated meat. She details how companies like Impossible Foods and Beyond Meat use fermentation to produce heme and high-moisture extrusion for texture, while noting that plant-based products currently cost 2-4x more than conventional meat due to scale disparities. Specht highlights a critical bottleneck in fermentation infrastructure, specifically a global shortage of large-scale bioreactors, and discusses how precision fermentation and cultivated meat aim to replicate the sensory experience of animal tissue more faithfully than plant-based options alone.

Mentioned

Companies
Good Food Institute, Impossible Foods, Beyond Meat, JBS, Mycotechnology, Nature's Fynd, Geloura
Also
CE Delft, heme protein, bioreactors

Other shows on the same ground, closest first.

  • How I Built This · 25m

    Live Episode! Beyond Meat: Ethan Brown

    Ethan Brown, founder and CEO of Beyond Meat, explains how he transitioned from a career in hydrogen fuel cells to creating plant-based meat products using pea and lentil protein. He details the early challenges of funding the venture by selling his home, importing textured soy protein from Taiwan, and collaborating with University of Missouri researchers to develop extrusion technology. Brown discusses the company's evolution from a garage startup to scaling production in dedicated facilities, aiming to make plant-based meat indistinguishable from animal meat in taste and texture.

  • Hard Tech Podcast · 6m

    3D Printed Fish And Meat, An In-depth Look Into The Future Of Food Tech | Hard Tech #2

    Host Danny Lapo discusses the emerging technology of 3D printed meat and fish, highlighting efforts by researchers at Osaka University to print Wagyu beef and companies like Stakeholder Foods and Umami Meats to produce fish fillets. The episode covers the biological process of using stem cells as bioink, the potential for luxury applications like caviar, and the significant hurdles regarding high costs, regulatory approval from the FDA, and environmental trade-offs.

  • How I Built This · 1h 03m

    Impossible Foods: Pat Brown

    Pat Brown, a former Stanford biochemist, explains how he left a tenured career to found Impossible Foods with the mission of creating plant-based meat that appeals to meat-eaters to reduce environmental impact. He details the scientific journey to isolate heme (specifically leghemoglobin) to replicate the taste and 'bleeding' of beef, including an expensive early failure to extract it from soybean root nodules. Brown discusses the strategic decision to launch in high-end restaurants with chefs like David Chang for credibility before scaling to mass market via Burger King, and the massive capital investments required to build fermentation capacity ahead of demand.

  • How I Built This · 38m

    When your dinner is printed with Eshchar Ben-Shitrit of Redefine Meat

    Eshchar Ben-Shitrit, co-founder and CEO of Redefine Meat, explains how he pivoted from a corporate career at HP to launching a plant-based meat company using 3D printing technology. He details the early R&D process, including initial failures with inedible prototypes and the strategic pivot from selling printers to selling the meat itself. Ben-Shitrit discusses the challenges of replicating complex muscle structures, securing partnerships with Michelin-starred chefs like Marco Pierre White, and the company's path to profitability and global expansion.

  • How I Built This · 42m

    Reimagining seafood production with Aryé Elfenbein and Justin Kolbeck of Wildtype (2022)

    Aryé Elfenbein and Justin Kolbeck, co-founders of Wildtype, explain how they pivoted from cultivating foie gras to growing cultivated salmon to address global seafood scarcity and contamination. They detail the technical challenges of scaling cell culture, including designing custom bioreactors and overcoming contamination setbacks that caused months of delays. The founders discuss their strategy to secure FDA approval and partner with high-end restaurants before scaling to broader retail, emphasizing the urgency of creating a third source of seafood to protect ocean biodiversity.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Catalyst. The episode itself belongs to its publisher.